Singapore stocks wrapped up the week on a positive note, with the Straits Times Index (STI) climbing 0.7% on Friday. The benchmark index, which tracks the performance of the top 30 companies listed on the Singapore Exchange, ended the session at 5,469.29, up 35.41 points from Thursday's close. The move came as optimism about artificial intelligence (AI)-related demand lifted sentiment across regional markets.
The STI traded in a relatively tight range during the day, but the overall tone was buoyed by a broader AI-driven rally that has been boosting tech and industrial stocks globally. This week's gains in Singapore mirrored similar moves in other Asian markets, such as Hong Kong stocks edging higher on a chip rally and Japan's Nikkei surging on AI chip stocks.
Key Movers: Marco Polo Marine and China Aviation Oil
Two stocks stood out among the gainers. Offshore-services firm Marco Polo Marine rose more than 2% after its unit, PKR Offshore, signed a framework agreement with Siemens Gamesa Renewable Energy. The deal covers two commissioning service operation vessels, which are specialized ships used to support the installation and maintenance of offshore wind turbines. This agreement underscores the growing demand for renewable energy infrastructure and positions Marco Polo Marine to benefit from the global push toward cleaner power.
Fuel supplier China Aviation Oil (Singapore) also gained more than 2% after its controlling shareholder completed a restructuring. The restructuring left China Petrochemical Corp. (Sinopec) owning 100% of China National Aviation Fuel, the parent company of China Aviation Oil. This move simplifies the ownership structure and could lead to more strategic alignment with Sinopec's broader operations, potentially benefiting the Singapore-listed entity.
Foundation Healthcare: A Cautionary Tale for New Listings
Not all stocks participated in the rally. Healthcare listing Foundation Healthcare fell nearly 3% on Friday, even after its stabilizing manager, UBS AG, bought 4.5 million shares on July 9 at prices ranging from SG$0.705 to SG$0.735. A stabilizing manager is a financial institution appointed after a company's initial public offering (IPO) to support the stock price by placing buy orders for a limited period, typically 30 days. This mechanism is designed to reduce early volatility and prevent disorderly drops as the market absorbs the new shares.
The fact that Foundation Healthcare's price still slid while UBS was actively buying suggests that selling pressure from everyday investors is overwhelming the temporary backstop. For investors, this is a signal that the stock could remain more volatile than the broader STI in the near term. The market is effectively testing where the "real" demand lies once the stabilizing support fades. This situation is not uncommon for newly listed companies, but it highlights the risks of investing in IPOs without a clear understanding of the post-listing dynamics.
What It Means for Investors
The STI's modest gain on Friday reflects a cautiously optimistic mood among investors, driven by AI-related enthusiasm that has been a key theme in global markets this year. However, the divergence between the winners and losers underscores the importance of stock-specific factors. For everyday investors, the takeaway is that while broad market trends matter, individual company news—such as contract wins or corporate restructuring—can have an outsized impact on portfolio returns.
Looking ahead, investors will be watching for further developments in the AI space, as well as economic data from major economies like the US and China. The rally in Asia chip stocks has been a tailwind for the region, but any signs of a slowdown in AI investment could reverse the trend. For now, the STI's ability to hold above the 5,400 level is a positive sign, but the market's narrow leadership suggests that gains may not be broad-based.
In the case of Foundation Healthcare, the stock's decline despite stabilizing manager support serves as a reminder that IPOs carry inherent risks. Investors should carefully evaluate a company's fundamentals and the market's reception before jumping in. The broader lesson is that even in a rising market, not all stocks are created equal.
